Picture of Tchaikapharma High Quality Medicines AD logo

THQM Tchaikapharma High Quality Medicines AD Cashflow Statement

0.000.00%
bg flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Annual cashflow statement for Tchaikapharma High Quality Medicines AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital-8.72-10.5-12.1-15.6-9.47
Other Operating Cash Flow
Cash from Operating Activities2.022.462.863.361.14
Capital Expenditures-1.91-2.17-0.636
Purchase of Fixed Assets
Other Investing Cash Flow Items-1.57-1.58
Purchase of Investments
Cash from Investing Activities-1.57-1.58-1.91-2.17-0.636
Financing Cash Flow Items0.004-0.273-0.499-0.601-0.223
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.457-0.796-1.02-1.13-0.482
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.0050.085-0.0690.0670.026